Assuming week is required, the following results were found.

  • The IDA Is Championing a Symbol for Invisible Disabilities - Multiple Sclerosis News Today

    This is not the week to tell me how good I look … even if I look and feel good. The week of Oct. 13 is Invisible Disabilities Week. As we all know, multiple sclerosis (MS) can be as invisible as Casper the Ghost. Invisible Disabilities Week isn’t...

    https://mschristian.org/index.php/blog/the-ida-is-championing-a-symbol-for-invisible-disabilities-multiple-sclerosis-news-today
  • MS & Socializing: A Few Things to Remember

    when I follow a routine and go to familiar places. Getting out is difficult for me, so I often set aside astandard day every week to get out. I have a set plan to go to a local bar and play trivia with a group of friends. I know I’m doing it every week,...

    https://mschristian.org/index.php/blog/ms-socializing-a-few-things-to-remember
  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    Click here to subscribe to the MS Beacon e-Newsletter by MS Views and News Continuing Tysabri (natalizumab) treatment up to week 28 of pregnancy, and restarting soon after birth, reduces the risk of relapses in women with multiple sclerosis and appears...

    https://mschristian.org/index.php/blog/ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds
  • Tecfidera (dimethyl fumarate)

    stomach upset stomach pain diarrhea nausea vomiting itchy skin rash These side effects may decrease or go away within a few weeks. If they're more severe or don't go away, talk to your doctor orpharmacist. Serious side effects Call your doctor right...

    https://mschristian.org/index.php/blog/tecfidera-dimethyl-fumarate
  • #ECTRIMS2019 – Data Shows Ublituximab’s Long-term Safety in Relapsing MS, TG Therapeutics Announced

    ublitiximab at three different doses in three groups of patients (eight per group; infusions given on days 1 and 15 and week 24, and accelerated in two cohorts). In addition to safety and accelerated infusion tolerability, this initial part was to...

    https://mschristian.org/index.php/blog/ectrims2019-data-shows-ublituximab-s-long-term-safety-in-relapsing-ms-tg-therapeutics-announced
  • 'We're Just Out of Shape and Weak': What We Heard This Week

    Director Anne Schuchat, MD, discussing the vaping-related lung illness that surged passed 1,000 cases and 18 deaths this week. "Then the surprise came with survival... this was completely unexpected." -- Joyce O'Shaugnessy, MD, of Baylor-Sammons Cancer...

    https://mschristian.org/index.php/blog/we-re-just-out-of-shape-and-weak-what-we-heard-this-week
  • Studies Report on Efforts to Optimize Rituximab in MS, NMOSD - The Center for Biosimilars

    treatment should occur, or what therapies may be optimal after treatment with the product is discontinued. During last week’s 35th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis, which was held in Stockholm,...

    https://mschristian.org/index.php/blog/studies-report-on-efforts-to-optimize-rituximab-in-ms-nmosd-the-center-for-biosimilars
  • Boston Children's Hospital researchers seem to have pinpointed the cause of multiple sclerosis

    the specific helper T cells that cause MS, as well as a protein on their surface that marks them. As reported this week in PNAS, an antibody targeting this protein, CXCR6, both prevented and reversed MS in a mouse model. A population of helper T cell...

    https://mschristian.org/index.php/blog/boston-children-s-hospital-researchers-seem-to-have-pinpointed-the-cause-of-multiple-sclerosis
  • Pregnancy & MS - Considerations before starting a family

    I were overjoyed. My pregnancy was very positive. I embraced the emotions and moments of that time. We took pictures every week of my growing belly and settled on the name Jacob when we found out we were having a boy. Nine months later, my husband and I...

    https://mschristian.org/index.php/blog/pregnancy-ms-considerations-before-starting-a-family
  • DNR Tattoo: MD JD Bangs the Gavel

    together. We select an ethical dilemma from a true, but anonymized patient care case, and then we seek a legal ruling. Last week, you voted on a DNR tattoo case. Here are the results from 1580 votes: 1. Do you comply with the DNR tattoo or not? Yes:...

    https://mschristian.org/index.php/blog/dnr-tattoo-md-jd-bangs-the-gavel
  • St. Cloud therapist diagnosed with MS running across the state - St. Cloud Times

    run." Mickelson committed to a training schedule at the beginning of June. He ran five miles a day before work five days a week, and on another day he would run double that distance. Chad Mickelson poses with a trail sign during his run across...

    https://mschristian.org/index.php/blog/st-cloud-therapist-diagnosed-with-ms-running-across-the-state-st-cloud-times
  • MS Walk fundraiser planned - Muskogee Daily Phoenix

    Event Center on Oct. 5. If that wasn't enough, she works out with a personal trainer at Strictly Fitness in Muskogee twice a week. This is a 60-year-old woman, married with two sons and four grandchildren, who has been restricted to a wheelchair for...

    https://mschristian.org/index.php/blog/ms-walk-fundraiser-planned-muskogee-daily-phoenix
  • Pay-to-Play Clinical Trials; Immune Tx Rationing; Small Pharmacies, Big Opioid Pushers

    Today) -- This past week in healthcare investigations Original link (MedPage Today) -- This past week in healthcare investigations Original link

    https://mschristian.org/index.php/blog/pay-to-play-clinical-trials-immune-tx-rationing-small-pharmacies-big-opioid-pushers
  • Following vapers

    users’ vaping and track their devices. The Juul C1, as the device is known, started selling in the United Kingdom this week after a successful pilot in Canada. Dan Thomson, managing director of Juul’s U.K. business, said that in order to use the device,...

    https://mschristian.org/index.php/blog/following-vapers
  • Avonex FDA- approved

    * weekly low dose interferon * for relapsing-remitting MS * protects against severe relapses * intramuscular injection once a week * side effects: flu like symptoms * depression and liver dysfunction less common * approved in 1996

    https://mschristian.org/index.php/articles/ms-medications/14-avonex-fda-approved
  • How childhood viral infections may later drive multiple sclerosis

    another of very young ones. "In both cases, the mice showed no signs of the disease and eliminated the infection within a week with a similar anti-viral immune response," notes study co-author Karin Steinbach, Ph.D. For the second step of the research,...

    https://mschristian.org/index.php/blog/how-childhood-viral-infections-may-later-drive-multiple-sclerosis
  • DOUBT Study Clarifies Role of MRI for TIA or Stroke

    MRI (e.g., axial DWI, fluid-attenuated inversion recovery, or gradient recalled echo). "The MRI can be done in the first week as an outpatient," noted co-author Michael Hill, MD, a neurologist at Alberta Health Services' Foothills Medical Centre and...

    https://mschristian.org/index.php/blog/doubt-study-clarifies-role-of-mri-for-tia-or-stroke
  • Rebif (interferon-beta-1a) FDA-approved

    * subcutaneous injection three times a week * interferon * for relapsing-remitting MS * reduces relapse rate * side effects: flu like symptoms * approved in 2002

    https://mschristian.org/index.php/articles/ms-medications/16-rebif-interferon-beta-1a-fda-approved

Results 1 - 18 of 18
 
 

Follow Us on Twitter

Follow Us On Twitter - Image